Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study

A comprehensive review found that patients who take aspirin have a relatively lower risk of developing various types of cancer.
Aspirin Inhibits Metastatic Cancer Spread, Reducing Mortality by 21 Percent: Study
Freepik
|Updated:
0:00

Aspirin is a long-established and widely used medication with a long history. In addition to its well-known uses for pain relief and its anti-inflammatory and anticoagulant properties, a recent study indicates that cancer patients who take low-dose aspirin daily experience a 21 percent reduction in mortality.

There’s also evidence of aspirin’s role in preventing cancer metastasis.